カリフォルニア州における子宮内膜がんの臨床試験
カリフォルニア州内の拠点で、子宮内膜がんに関する73件の研究が参加者を募集しています。
カリフォルニア州内の都市
- Los Angeles34件の研究
- Baldwin Park17件の研究
- San Diego16件の研究
- San Francisco14件の研究
- Mountain View12件の研究
- Orange10件の研究
- Santa Monica10件の研究
- Irvine9件の研究
- Newport Beach7件の研究
- Sacramento7件の研究
- Santa Rosa6件の研究
- Santa Barbara3件の研究
- Concord3件の研究
- Vallejo3件の研究
公式研究テキスト（英語）
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- PCR Oncology, Arroyo Grande
- Mercy Cancer Center - Carmichael, Carmichael
- Mercy San Juan Medical Center, Carmichael
- 他15件
被験者募集中第2相
全年齢 · 全性別 · 2026/10/02更新 · NCT05564377The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of San Diego Moores Cancer Center, La Jolla
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750Distance-Based Exercise to Preserve Function and Prevent Disability
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- 他10件
被験者募集中
18歳以上 · 全性別 · 2026/10/02更新 · NCT07059884Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- Mercy Cancer Center - Carmichael, Carmichael
- Mercy San Juan Medical Center, Carmichael
- Kaiser Permanente Dublin, Dublin
- 他26件
被験者募集中第3相
18歳以上 · 女性 · 2026/10/02更新 · NCT07198074A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- City of Hope - Duarte Cancer Center, Duarte
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06760819A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- University of California - Los Angeles, Los Angeles
被験者募集中第1相
19歳以上 · 全性別 · 2026/10/01更新 · NCT06586957A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- City of Hope, Duarte
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
- Research Site, Duarte
- Research Site, Los Angeles
- Research Site, Newport Beach
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06218914A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
- City of Hope Comprehensive Cancer Center, Duarte
- The City of Hope Orange County Lennar Foundation Cancer Center, Irvine
- Chao Family Comprehensive Cancer Center, Orange
被験者募集中第1/2相
18歳以上 · 女性 · 2026/09/24更新 · NCT04590326Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
- Cedars-Sinai Medical Center, Los Angeles
- Huntington Memorial Hospital, Pasadena
- Sutter Medical Center Sacramento, Sacramento
被験者募集中第2相
18歳以上 · 女性 · 2026/09/24更新 · NCT05640999A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
- Kivu Trial Site, Santa Monica
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/24更新 · NCT07229313Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Research Site, Los Angeles
- Research Site, Santa Rosa
被験者募集中第2相
18歳〜130歳 · 全性別 · 2026/09/23更新 · NCT05489211Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- UC IRVINE Health, Orange
- UC Davis Comprehensive Cancer Center, Sacramento
- Stanford Cancer Institute, Stanford
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- City of Hope, Duarte
- University of California, Los Angeles (UCLA), Santa Monica
- Stanford University Medical Center, Stanford
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07114601EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- California Research Institute (CRI), Los Angeles
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07262619Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Beverly Hills Cancer Center, Beverly Hills
- City of Hope Cancer Center, Duarte
- University of California Irvine Medical Center, Orange
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05983432A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 5014), Irvine
- University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 6020), Orange
- Sansum Clinic (Ridley Tree) ( Site 8007), Solvang
- 他1件
被験者募集中第3相
18歳以上 · 女性 · 2026/09/17更新 · NCT06952504A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- City of Hope, Duarte
- City of Hope, Irvine, Irvine
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07109726ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- University of California, San Diego, La Jolla
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Redwood City, Redwood City
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Santa Monica
- Research Site, Santa Rosa
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT05123482Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- City of Hope, Duarte
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
- 他1件
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06293898Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
- Kaiser Permanente SoCal, Irvine
- CPMC Research Institute, San Francisco
被験者募集中第3相
18歳以上 · 女性 · 2026/09/09更新 · NCT07166094A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06400472DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, Duarte
- Research Site, Irvine
- Research Site, La Jolla
被験者募集中第3相
18歳以上 · 女性 · 2026/09/03更新 · NCT06989112FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- UC San Diego Moores Cancer Center, La Jolla
- University of Southern California, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/02更新 · NCT07216105A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- UC San Diego Moores Cancer Center, San Diego
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/27更新 · NCT07227168A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
- START Los Angeles, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/26更新 · NCT07383506Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- City of Hope, Duarte
- Stanford, Palo Alto
- University of California, San Francisco
被験者募集中第1相
15歳以上 · 全性別 · 2026/08/25更新 · NCT06276491Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital Los Angeles, Los Angeles
- Children's Hospital of Orange County, Orange
- UCSF Medical Center-Mission Bay, San Francisco
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Hoag Family Cancer Institute, Newport Beach
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/21更新 · NCT06774963Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
- Research Site, Duarte
- Research Site, Irvine
被験者募集中第1/2相
18歳〜130歳 · 全性別 · 2026/08/21更新 · NCT05797168A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours)
- Valkyrie Clinical Trials, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/21更新 · NCT07306559A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
- City of Hope National Medical Center, Duarte
- UC San Diego Moores Cancer Center, La Jolla
- Cedars Sinai Medical Center, Los Angeles
- 他4件
被験者募集中第2相
18歳以上 · 女性 · 2026/08/21更新 · NCT05548296Hypofractionated External Beam Radiotherapy With Adaptive Planning for Endometrial and Cervical Cancers
- University of California at Los Angeles, Los Angeles
被験者募集中
18歳以上 · 女性 · 2026/08/20更新 · NCT06538337A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
- START - Los Angeles, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07470853FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of California, Los Angeles (UCLA), Los Angeles
- Stanford Cancer Institute, Stanford University, Palo Alto
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
- 他1件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT05919264A Study of PHST001 in Advanced Solid Tumors
- Precision NextGen Oncology & Research Center, Beverly Hills
- USC Norris Comprehensive Cancer Center, Los Angeles
- Stanford University School of Medicine, Palo Alto
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/12更新 · NCT06840886A Study of MGC026 in Participants With Advanced Solid Tumors
- The Angeles Clinic and Research Institute, Los Angeles
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/11更新 · NCT06242470A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
- City of Hope at Arcadia, Arcadia
- City of Hope Medical Center, Duarte
- City of Hope at Seacliff, Huntington Beach
- 他8件
被験者募集中
18歳以上 · 女性 · 2026/08/10更新 · NCT07741968ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。